CLINICAL_TRIALS
trial_result
· 2021-02-02
Clinical Trial Update: Sitagliptin for the Treatment of Grade 3-4 and Refractory Acute Graft-versus-host Disease [Phase 2]
Summary
A Phase 2 clinical trial evaluating sitagliptin for grade 3-4 and refractory acute graft-versus-host disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rabin Medical Center | Conditions: Graft Vs Host Disease | Phase 2 | Status: UNKNOWN